|
NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan. 2, 2004--Renal Care Group, Inc.
(NYSE:RCI - News) today announced its participation at JP Morgan's
22nd Annual Healthcare Conference to be held January 12-15, 2004, at
the Westin St. Francis Hotel in San Francisco. Mr. David M. Dill, executive
vice president and chief financial officer of Renal Care Group, will
discuss the Company's recent business developments and operating strategies.
A live audio broadcast of Renal Care Group's presentation will be available
on Tuesday, January 13, 2004, from 1:00 p.m. to 1:25 p.m. Eastern Time.
To access the broadcast, listeners should go to the "Investors" section
of the Company's web site, www.renalcaregroup.com,
approximately 15 minutes prior to the event to register and to download
any necessary software.
For those unable to listen to the live broadcast, a replay will begin
at 3:00 p.m. Eastern Time that day and will be available on the Company's
web site. Renal Care Group is a specialized dialysis services company that provides
care to patients with kidney disease. The Company treats over 21,300
patients at more than 270 owned outpatient dialysis facilities, in addition
to providing acute dialysis services at more than 120 hospitals. Over
6,500 associates provide services across the Company's 27-state network.
More information about Renal Care Group, Inc. can be found at www.renalcaregroup.com.
Certain statements in this press release constitute "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements, which are usually
preceded by words like expect, plan, intend, will and the like, include
statements regarding our future performance and any other statements
that necessarily depend on future events. These forward-looking statements
reflect management's expectations and are based upon currently available
information. These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause actual results,
performance or achievements of Renal Care Group to differ materially
from those expressed in or implied by the forward-looking statements,
including risks related to: dependence on executive officers; changes
in the Medicare and Medicaid programs; payment reductions by private
insurers, hospitals or managed care organizations; changes in the health
care delivery, financing or reimbursement systems; risks related to the
drug Epogen (EPO); compliance with health care and other applicable laws;
and the integration of acquired companies. These and other factors affecting
the Company are discussed in more detail in Renal Care Group's reports
filed with the Securities and Exchange Commission, including without
limitation Renal Care Group's most recent annual report on Form 10-K
and any quarterly reports on Form 10-Q filed after that annual report.
Upon request, copies of these filings are available from Renal Care Group.
Contact:
Renal Care Group, Inc., Nashville
Terry L. Proveaux, 615-345-5577
|
Press Releases